An up to date blog on the latest trends, news and developments within the pharmaceutical packaging industry.
When a new drug hits the development stage it can go through a lengthy and complex process before it is seen by the public or distributed to pharmacies. In reality, only two tested innovations out of 10,000 actually become fully licensed treatments. All in all, it can take an average of ten to fifteen years…
Sunday, April 7th is World Health Day, an annual campaign built to increase global awareness of universal health coverage with a particular focus on what services should be available. The event Is organized by the World Health Organization, and signals a major date in their calendar. But exactly who is WHO, and what are their…
Origin Pharma Contributed an article to EPM Magazine – full story below Like every industry, the pharma sector is poised on the edge of its seat in anticipation of a final agreement on Brexit. The UK will officially leave the European Union on March 29th (if all goes to plan) and the terms of the…
By Rich Quelch, Global Head of Marketing, Origin Pharmaceutical packaging is an industry going from strength to strength and its shows no signs of slowing down. In fact, by 2025 the market is expected to be worth $128 billion. The main drivers of this growth are: increased global demand for medication from emerging economies; an ageing…
By Rich Quelch, Global Head of Marketing, Origin Antimicrobial resistance (AMR) is a complex and global issue, affecting all regions of the world. If current trends continue, it’s believed by 2050 antibiotic resistance will cause more deaths per year than cancer, becoming the world’s biggest killer. As such, AMR is currently high on the political…
It’s very easy to go about your day to day life without thinking about the impact the products you buy and use have on the environment. Although there has been a surge in interest in single-use plastics, the reality is that many of us aren’t aware of the damage we’re doing to the planet. Every…
GSK, Bristol-Myers Squibb, Novartis and AstraZeneca to name but a few are investing billions of dollars in biologics to have prime mover advantage in a market forecast to be worth nearly $480 billion by 2024. It’s clear biologics are the future of medicine based on their proven ability to treat major chronic diseases better than…
As legislation and ethical awareness evolves, Origin Pharma Packaging has seen the demand for innovative design and production of child safe packaging increase on a global scale. Our new product development (NPD) team are continually investing their time and knowledge developing commercial solutions for child resistant compliant packaging for the UK, Europe, the U.S.A and…
Meeting in Nairobi in December 2017, the United Nations Environment Assembly committed to a new resolution, urging all countries, ‘to prevent and significantly reduce marine pollution of all kinds, in particular from land-based activities’ by 2025. It claims, unless we take action, our oceans will contain more plastic than fish by 2050. The call to…
Pharmaceuticals companies are experiencing a wave of competing challenges as part of what PwC refers to as the New Health Economy. These include market consolidation for efficiency gains; the changing demands and needs of patients and increasing cost pressures from payors leading to calls for pricing reform. Jon Lant, Head of New Product Development & Innovation,…